masthead

FOUNDATIONONE®

nustato daugumos metastazavusiu arba recidyvavusiu solidiniu vėžiu (naviku) sergančių pacientų gydymo galimybes

Literatūra
  1. FoundationOne technical information.
  2. Drilon A et al. Clin Cancer Res 2015; 16:3631–3639.
  3. Rozenblum AB et al. J Thorac Oncol 2017; 2:258–268 (and supplementary material).
  4. Roche Foundation Medicine data on file: Internal presentation. Lab processes: deep dive.
  5. Roche Foundation Medicine Internal Information. 
  6. Roche Foundation Medicine data on file: Strategy internal presentation.
  7. Schwaederle M et al. Mol Cancer Ther 2015; 14:1488–1494.
  8. Genomeweb. Foundation Medicine Q3 revenues up 45 percent. Available at: https://www.genomeweb.com/molecular-diagnostics/foundation-medicine-q3-revenues-45-percent [accessed November 2017].